SCHEMBL13148019

SCHEMBL13148019

O=C(Nc1ccccc1N1CCCCC1)c1cc([N+](=O)[O-])c[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 4/20 1.00
MAPT P10636 5/20 0.66
GAA P10253 4/20 0.66
KMT2A Q03164 3/20 0.59
SMN1; SMN2 Q16637 3/20 0.58
L3MBTL1 Q9Y468 2/20 0.58
LMNA P02545 1/20 0.58
HPGD P15428 1/20 0.58
ALOX12 P18054 1/20 0.58
CCR6 P51684 1/20 0.58
KCNH2 Q12809 1/20 0.58
POLB P06746 2/20 0.55
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
ALDH1A1 P00352 5/20 0.54
NPSR1 Q6W5P4 2/20 0.54
MAPK1 P28482 1/20 0.53
MEN1 O00255 2/20 0.53
TDP1 Q9NUW8 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3087034 0.80 MAPT (1.00) CSF1RMAPTGAAKMT2ASMN1; SMN2
SCHEMBL13148139 0.79 CSF1R (0.66) CSF1RMAPTGAAKMT2ASMN1; SMN2
SCHEMBL13148058 0.77 MAPT (0.68) CSF1RMAPTGAAKMT2ASMN1; SMN2
Nitrobenzene SCHEMBL28169097 0.76 GAA (0.67) CSF1RMAPTGAAKMT2ASMN1; SMN2
SCHEMBL13148083 0.76 CSF1R (0.61) CSF1RMAPTGAAKMT2ASMN1; SMN2
SCHEMBL3978132 0.75 ALDH1A1 (0.78) CSF1RMAPTGAAKMT2ASMN1; SMN2
SCHEMBL12582512 0.74 GAA (0.62) CSF1RMAPTGAAKMT2ASMN1; SMN2
SCHEMBL5049551 0.74 ALOX5 (0.60) CSF1RMAPTKMT2ASMN1; SMN2LMNA
SCHEMBL14078174 0.73 CSF1R (0.58) CSF1RMAPTKMT2ASMN1; SMN2L3MBTL1
SCHEMBL13148038 0.73 CSF1R (1.00) CSF1RGAAKMT2ALMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 US disclosed
US-7790724-B2 c-fms kinase inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2010-09-07 US disclosed
US-7429603-B2 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2008-09-30 US disclosed
US-7429603-B2 Such as 5-nitro-furan-2-carboxylic acid (2-piperidin-1-yl-phenyl)-amide; diabetes, angiogenesis, psoriasis, restenosis, schizophrenia, rheumatoid arthritis, cardiovascular disease, cancer 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2008-09-30 US disclosed